Výsledky vyhľadávania - "Abraham, Prema"

Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-Related Macular Degeneration: PIER Study Year 2 Autor Abraham, Prema, Yue, Huibin, Wilson, Laura

“…To evaluate efficacy and safety of quarterly (and then monthly) ranibizumab during the 2-year Phase IIIb, multicenter, randomized, double-masked, sham…”
Získať plný text

Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1 Autor Regillo, Carl D., Brown, David M., Abraham, Prema, Yue, Huibin, Ianchulev, Tsontcho, Schneider, Susan, Shams, Naveed

“…To evaluate the efficacy and safety of ranibizumab administered monthly for three months and then quarterly in patients with subfoveal choroidal…”
Získať plný text

Prospective evaluation of the incidence and risk factors for the development of RPE tears after high- and low-dose ranibizumab therapy Autor Sarraf, David, Chan, Clement, Rahimy, Ehsan, Abraham, Prema

“…To prospectively determine the incidence and risk factors for retinal pigment epithelial (RPE) tears in eyes with vascularized pigment epithelial detachments…”
Zistit podrobnosti o prístupe

Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in diabetes (READ-2) study Autor Nguyen, Quan Dong, Shah, Syed Mahmood, Heier, Jeffery S, Do, Diana V, Lim, Jennifer, Boyer, David, Abraham, Prema, Campochiaro, Peter A

“…To compare ranibizumab with focal/grid laser or a combination of both in diabetic macular edema (DME). Prospective, randomized, interventional, multicenter…”
Zistit podrobnosti o prístupe

Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study Autor Nguyen, Quan Dong, Shah, Syed Mahmood, Khwaja, Afsheen A, Channa, Roomasa, Hatef, Elham, Do, Diana V, Boyer, David, Heier, Jeffery S, Abraham, Prema, Thach, Allen B, Lit, Eugene S, Foster, Bradley S, Kruger, Erik, Dugel, Pravin, Chang, Thomas, Das, Arup, Ciulla, Thomas A, Pollack, John S, Lim, Jennifer I, Eliott, Dean, Eliot, Dean, Campochiaro, Peter A

“…To determine the long-term effects of ranibizumab (RBZ) in patients with diabetic macular edema (DME). Prospective, randomized, interventional, multicenter…”
Zistit podrobnosti o prístupe

Primary endpoint results of a phase II study of vascular endothelial growth factor trap-eye in wet age-related macular degeneration Autor Brown, David M, Heier, Jeffrey S, Ciulla, Thomas, Benz, Matthew, Abraham, Prema, Yancopoulos, George, Stahl, Neil, Ingerman, Avner, Vitti, Robert, Berliner, Alyson J, Yang, Ke, Nguyen, Quan Dong

“…To evaluate the biologic effects and safety of vascular endothelial growth factor (VEGF) Trap-Eye during a 12-week fixed-dosing period in patients with…”
Zistit podrobnosti o prístupe

Ranibizumab for choroidal neovascularization secondary to causes other than age-related macular degeneration: a phase I clinical trial Autor Heier, Jeffrey S, Brown, David, Ciulla, Thomas, Abraham, Prema, Bankert, Joy M, Chong, Sandy, Daniel, Jr, Paul E, Kim, Ivana K

“…To investigate the safety and efficacy of ranibizumab for the treatment of choroidal neovascularization (CNV) secondary to causes other than age-related…”
Zistit podrobnosti o prístupe

Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration Autor Chan, Clement K, Meyer, Carsten H, Gross, Jeffrey G, Abraham, Prema, Nuthi, Asha S D, Kokame, Gregg T, Lin, Steven G, Rauser, Michael E, Kaiser, Peter K

“…To study retinal pigment epithelium (RPE) tears after off-label intravitreal bevacizumab (Avastin; Genentech, Inc., South San Francisco, CA) injection for…”
Zistit podrobnosti o prístupe

Meticulous multimodal analysis of aflibercept therapy for submacular vascularized pigment epithelial detachment associated with neovascular AMD in a prospective case series, the EVEN study Autor Chan, Clement K., Sarraf, David, Abraham, Prema, Lalezary, Maziar, Lin, Steven G., Chen, Xuejing, Nittala, Muneeswar Gupta, Sadda, SriniVas

“…This prospective case series investigates the visual and anatomical outcomes including detailed volumetrics of eyes with vascularized pigment epithelial…”
Získať plný text

Intravitreal bevacizumab (avastin) in central retinal vein occlusion Autor Hsu, Jason, Kaiser, Richard S, Sivalingam, Arunan, Abraham, Prema, Fineman, Mitchell S, Samuel, Michael A, Vander, James F, Regillo, Carl D, Ho, Allen C

“…To describe the effects of intravitreal bevacizumab in eyes with macular edema resulting from central retinal vein occlusions (CRVO). Retrospective consecutive…”
Zistit podrobnosti o prístupe

Clinical evaluation of the safety and efficacy of preservative-free triamcinolone (triesence [triamcinolone acetonide injectable suspension] 40 mg/ml) for visualization during pars plana vitrectomy Autor Dyer, David, Callanan, David, Bochow, Thomas, Abraham, Prema, Lambert, H Michael, Lee, S Young, Schneiderman, Todd, Potts, Susan L, Walker, Thomas M

“…To evaluate the safety and efficacy of preservative-free triamcinolone (TRIESENCE(R) suspension) for visualization during pars plana vitrectomy. This phase…”
Zistit podrobnosti o prístupe

Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Phase 2 Trial Autor Liao, David S, Grossi, Federico V, El Mehdi, Delphine, Gerber, Monica R, Brown, David M, Heier, Jeffrey S, Wykoff, Charles C, Singerman, Lawrence J, Abraham, Prema, Grassmann, Felix, Nuernberg, Peter, Weber, Bernhard H F, Deschatelets, Pascal, Kim, Robert Y, Chung, Carol Y, Ribeiro, Ramiro M, Hamdani, Mohamed, Rosenfeld, Philip J, Boyer, David S, Slakter, Jason S, Francois, Cedric G

“…Geographic atrophy (GA), a late stage of age-related macular degeneration (AMD), is a major cause of blindness. Even while central visual acuity remains…”
Zistit podrobnosti o prístupe

Effect of High-Dose Intravitreal Aflibercept, 8 mg, in Patients With Neovascular Age-Related Macular Degeneration: The Phase 2 CANDELA Randomized Clinical Trial Autor Wykoff, Charles C, Brown, David M, Reed, Kimberly, Berliner, Alyson J, Gerstenblith, Adam T, Breazna, Aurora, Abraham, Prema, Fein, Jordana G, Chu, Karen W, Clark, W Lloyd, Leal, Sergio, Schmelter, Thomas, Hirshberg, Boaz, Yancopoulos, George D, Vitti, Robert

“…Aflibercept, 8 mg, may have greater therapeutic benefits compared with aflibercept, 2 mg, in patients with neovascular age-related macular degeneration (nAMD),…”
Zistit podrobnosti o prístupe

Post-hoc analysis of single nucleotide polymorphism profile for eyes with vascularized pigment epithelial detachment due to ARMD Autor Lee, Daniel, Chan, Clement K, Abraham, Prema, Sarraf, David

“…This post-hoc case-control study compares single nucleotide polymorphism (SNP) profile of eyes with vascularized pigment epithelial detachment (vPED) due to…”
Zistit podrobnosti o prístupe

Treatment outcomes of conventional or high-dose ranibizumab for vascularized pigment epithelial detachment based on lesion subtypes Autor Chan, Clement K, Sarraf, David, Abraham, Prema

“…A post hoc study was conducted to compare visual and anatomic outcomes of vascularized serous pigment epithelial detachment (Group 1) with fibrovascular…”
Zistit podrobnosti o prístupe

Single nucleotide polymorphism profiles associated with three common phenotypes of advanced age‐related macular degeneration Autor Ng, Caleb C., Chan, Clement K., Abraham, Prema, Hafner, Andre D.

Získať plný text

TYPE 1 VERSUS TYPE 3 NEOVASCULARIZATION IN PIGMENT EPITHELIAL DETACHMENTS ASSOCIATED WITH AGE-RELATED MACULAR DEGENERATION AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY: A Prospective Study Autor Chen, Xuejing, Al-Sheikh, Mayss, Chan, Clement K, Hariri, Amir H, Abraham, Prema, Lalezary, Maziar, Lin, Steven G, Sadda, SriniVas, Sarraf, David

“…To evaluate the response to aflibercept therapy for Type 1 and Type 3 neovascularization in pigment epithelial detachments associated with treatment-naive,…”
Zistit podrobnosti o prístupe

Twenty-four-Month Outcomes of the Ranibizumab for Edema of the Macula in Diabetes - Protocol 3 with High Dose (READ-3) Study Autor Sepah, Yasir J, Sadiq, Mohammad Ali, Boyer, David, Callanan, David, Gallemore, Ron, Bennett, Michael, Marcus, Dennis, Halperin, Lawrence, Hassan, Muhammad, Campochiaro, Peter A, Nguyen, Quan Dong, Do, Diana V

“…To compare 2.0 mg ranibizumab (RBZ) injections with 0.5 mg RBZ for eyes with center-involved diabetic macular edema (DME). Randomized, controlled,…”
Zistit podrobnosti o prístupe

Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy Autor Aiello, Lloyd Paul, Davis, Matthew D, Girach, Aniz, Kles, Keri A, Milton, Roy C, Sheetz, Matthew J, Vignati, Louis, Zhi, Xin Eric

“…To evaluate the effect of ruboxistaurin, an orally administered protein kinase C beta (PKC beta) isozyme-selective inhibitor, on vision loss in patients with…”
Zistit podrobnosti o prístupe

Optical coherence tomography-measured pigment epithelial detachment height as a predictor for retinal pigment epithelial tears associated with intravitreal bevacizumab injections Autor Chan, Clement K, Abraham, Prema, Meyer, Carsten H, Kokame, Gregg T, Kaiser, Peter K, Rauser, Michael E, Gross, Jeffrey G, Nuthi, Asha S D, Lin, Steven G, Daher, Noha S

“…The purpose was to study preinjection optical coherence tomography-related factors in age-related macular degeneration eyes with retinal pigment epithelial…”
Zistit podrobnosti o prístupe